Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies. In 2007, NIH / NIMH awarded Xhale an SBIR Phase I grant to test the technical merit of SMART.
Transcatheter Cardiovascular Therapeutics 2009
WHAT: Data from late-breaking clinical trials of new interventional techniques and devices will be released at TCT 2009 – Transcatheter Cardiovascular Therapeutics – the global annual scientific symposium of the Cardiovascular Research Foundation. Researchers will present a variety of new data that promises to advance the field of interventional cardiology. The TCT 2009 final program is now available at:
Cumulative Radiation Exposure From Imaging Scans Should Be Weighed Against The Benefits Say Researchers
US researchers found that repeated exposure to ionizing radiation from medical imaging such as x-rays, fluoroscopy, computed tomography (CT) and nuclear medicine scans can accumulate over time to substantial cancer-causing doses, and recommend that doctors and patients always weigh up the benefits of imaging against the risks.
Clarifying Conflict Of Interest Disclosures In Clinical Trials
When enrolling patients in a clinical trial, researchers should disclose relevant financial relationships that might affect a patient’s decision about participation, such as owning stock in the company that funds the study, or having a patent on the device being tested. It’s a process many believe builds trust and fulfills a patient’s right to know about financial conflicts of interest.
Cost-Effective Technology For Disease Diagnosis And Biological Research Developed By Singapore Scientists
A novel electronic sensor array for more rapid, accurate and cost-efficient testing of DNA for disease diagnosis and biological research has been developed by scientists at Singapore’s Institute of Bioengineering and Nanotechnology (IBN). In a recent Journal of the American Chemical Society, IBN scientists reported that based on laboratory results, their Nanogap Sensor Array has shown “excellent” sensitivity at detecting trace amounts of DNA.
Device For On The Spot Blood Analysis
A hand-held device which could offer point-of-care blood cell analysis in doctors’ surgeries is being developed by academics at the University of Southampton and is described in a paper in Lab on a Chip this month.
PAC Session On Patient Self-Monitoring With Warfarin Therapy, Australia
Antithrombotic agents (anticoagulant and antiplatelet drugs) are some of the most frequently prescribed medications in Australia and yet they are also often associated with adverse drug reactions. It is common to see antithrombotics used in various combinations, and in the elderly, which further increases the risk of adverse events, a situation made even more pertinent to pharmacists with a number of new antithrombotic medications available in Australia.
A Better Test To Detect DNA For Diagnosing Disease, Investigating Crimes
Researchers in Singapore are reporting development of a new electronic sensor that shows promise as a faster, less expensive, and more practical alternative than tests now used to detect DNA. Such tests are done for criminal investigation, disease diagnosis, and other purposes. The new lab-on-a-chip test could lead to wider, more convenient use of DNA testing, the researchers say. Their study is scheduled for the Sept.
New Technology Helps Parkinson’s Patients Speak Louder
Researchers have developed a new technology that helps Parkinson’s patients overcome the tendency to speak too quietly by playing a recording of ambient sound, which resembles the noisy chatter of a restaurant full of patrons. “People with Parkinson’s disease commonly have voice and speech problems,” said Jessica Huber, an associate professor in Purdue’s Department of Speech, Language and Hearing Sciences.
Toshiba Installs Milestone 800th Vantage MR System At Elkview General Hospital
Toshiba America Medical Systems, Inc., an industry leader in magnetic resonance (MR) technology, reached a significant achievement in installing its 800th Vantage™ 1.5T MR system at Elkview General Hospital in Hobart, Okla. Elkview is using the Vantage system for orthopedic, neuro and abdominal imaging.
Ruptured Brain Aneurysms: New Treatment Option
Researchers in Finland have identified an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published in the online edition of Radiology. An aneurysm is a bulge or sac that develops in a weak area of a cerebral artery wall.